CSS LLC’s Teva Pharmaceuticals TEVA Stock Holding History

CSS LLC’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-30,000	Closed	-$294K	–	753
2019 Q4	$294K	Hold	30,000	–	–	0.02%	434
2019 Q3	$207K	Hold	30,000	–	–	0.01%	441
2019 Q2	$277K	Hold	30,000	–	–	0.02%	388
2019 Q1	$471K	Sell	30,000 -150,000	-83%	-$2.65M	0.03%	319
2018 Q4	$2.77M	Buy	180,000 +30,000	+20%	+$615K	0.19%	112
2018 Q3	$3.23M	Hold	150,000	–	–	0.14%	110
2018 Q2	$3.65M	Sell	150,000 -10,000	-6%	-$204K	0.17%	97
2018 Q1	$2.74M	Buy	160,000 +50,000	+45%	+$976K	0.14%	124
2017 Q4	$2.09M	Buy	110,000 +69,500	+172%	+$1.05M	0.1%	146
2017 Q3	$713K	Buy	+40,500	New	+$911K	0.03%	292

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CSS LLC's TEVA Position: Q1 2026 in Review

CSS LLC held its Teva Pharmaceuticals (TEVA) position steady in Q1 2026 at 27,070 shares worth $815K. The position accounts for 0.04% of the portfolio, ranked #396.

CSS LLC first reported a position in TEVA in Q4 2018 and has held it in 8 quarters since. The position peaked at $845K in Q4 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

CSS LLC held 27,070 shares of Teva Pharmaceuticals worth $815K as of Q1 2026.
CSS LLC left its Teva Pharmaceuticals share count unchanged in Q1 2026.
Teva Pharmaceuticals made up 0.04% of CSS LLC's portfolio in Q1 2026, its #396 holding.
CSS LLC first reported a position in Teva Pharmaceuticals in Q4 2018 and has held it in 8 quarters since.
CSS LLC's Teva Pharmaceuticals position peaked at $845K in Q4 2025.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.